Search Result "COVID-19 main protease (3CL pro)"

Research Article

Virtual Screening of Chinese Medicine Small Molecule Compounds Targeting SARS-CoV-2 3CL Protease (3CL pro)

Journal: Letters in Drug Design & Discovery
Volume: 18 Issue: 4 Year: 2021 Page: 355-364
Author(s): Qingxiu He,Xin Chen,Xi Yang,Guangpin Li,Haiqiong Guo,Han Chu,Zhihua Lin,Yuanqiang Wang

Research Article

In Silico Screening of Some Anti-Cancer Drugs Against the Main Proteaseof COVID-19 Using Molecular Docking

Journal: Letters in Organic Chemistry
Volume: 20 Issue: 1 Year: 2023 Page: 77-90
Author(s):

Review Article

Promising Enzymes for Inhibitors Development Against COVID-19

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 22 Issue: 3 Year: 2022 Page: 449-456
Author(s): Zhi-Gang Sun,Feng-Ling Yu,Xiang-Ting Qiu,Shuang Li,Xue-Tang Li

Letter Article

Revealing Potential Binding Affinity of FDA Approved Therapeutics Targeting Main Protease (3CLpro) in Impairing Novel Coronavirus (SARSCoV- 2) Replication that Causes COVID-19

Journal: Coronaviruses
Volume: 1 Issue: 1 Year: 2020 Page: 98-107
Author(s): D. Sivaraman,P.S. Pradeep,S. Sundar Manoharan,C. Ramachandra Bhat,K.V. Leela,V. Venugopal

Review Article

Exploring the SARS-Cov-2 Main Protease (Mpro) and RdRp Targets byUpdating Current Structure-based Drug Design Utilizing Co-crystals toCombat COVID-19

Journal: Current Drug Targets
Volume: 23 Issue: 8 Year: 2022 Page: 802-817
Author(s): K.M. Rashmi

Research Article

QSAR of SARS-CoV-2 Main Protease Inhibitors Utilizing Theoretical MolecularDescriptors

Journal: Letters in Drug Design & Discovery
Volume: 21 Issue: 1 Year: 2024 Page: 116-132
Author(s): Anil Kumar Saxena

Research Article

In Silico Analysis of the Antidepressant Fluoxetine and Related Drugs atSARS-CoV-2 Main Protease (Mpro) and Papain-like Protease (PLpro)

Journal: Current Drug Discovery Technologies
Volume: 20 Issue: 2 Year: 2023 Page: 29-40
Author(s): Folorunsho Bright Omage,Cássia Pereira Delgado,Pablo Andrei Nogara

Research Article

Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19

Journal: Current Pharmaceutical Design
Volume: 27 Issue: 33 Year: 2021 Page: 3577-3589
Author(s): Md. Tabish Rehman,Mohamed F. AlAjmi,Afzal Hussain

Mini-Review Article

Would the Development of a Multitarget Inhibitor of 3CLpro andTMPRSS2 be Promising in the Fight Against SARS-CoV-2?

Journal: Medicinal Chemistry
Volume: 19 Issue: 5 Year: 2023 Page: 405-412
Author(s): Igor José dos Santos Nascimento,Ricardo Olimpio de Moura

Computational Methods for COVID-19 Treatment

Ebook: Coronavirus Disease-19 (COVID-19): A Perspective of New Scenario
Volume: 2 Year: 2021
Author(s): Muhammad Mazhar Munir,Muhammad Yasir Waqas,Muhammad Farrukh Nisar,Shaukat Hussain Munawar,Zahid Manzoor
Doi: 10.2174/9781681089072121020015

Previous   Next

Go To   Results 1 - 1 of 61

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


© 2025 Bentham Science Publishers | Privacy Policy